Optimale medicinale behandeling van vrouwen met verdenking van cardiale pijn op de borst. Een gerandomiseerd observationeel klinisch onderzoek.

Optimal spasmolytic medicinal treatment for women with cardiac suspected chestpain. A randomized obervational clinical trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON20207

Enrollment

Registered

2018-01-19

Start date

2018-04-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Angina pectoris, menopausal female

Interventions

no interventions

Eligibility

Inclusion criteria

Inclusion criteria: - female - cardiac suspected chestpain or chestdiscomfort - signed informed consent - good control dutch language

Exclusion criteria

Exclusion criteria: - cardiac medical history - present use of medication under investigation - known allergy for the medication under investigation

Design outcomes

Primary

Measure	Time frame
Reduced number of episodes of pain or discomfort on the chest	—

Contacts

Public ContactP.F.M.M. Bergen, van

P.vanBergen@westfriesgasthuis.nl+31 (0)229 208552

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)